RANDOMISED DOUBLE-BLIND TRIAL OF RECOMBINANT PRO-UROKINASE AGAINST STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
- 1 April 1989
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 333 (8643) , 863-868
- https://doi.org/10.1016/s0140-6736(89)92864-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.Heart, 1988
- Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1987
- A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): Long-term mortality and morbidityJournal of the American College of Cardiology, 1987
- Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?Circulation, 1986
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarctionJournal of the American College of Cardiology, 1986
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Increased Plasminogen Activator (Urokinase) in Tissue Culture After Fibrin DepositionJournal of Clinical Investigation, 1973